pmc.ncbi.nlm.nih.gov

Biochemical Identification of Citrobacter Species Defined by DNA Hybridization and Description of Citrobacter gillenii sp. nov. (Formerly Citrobacter Genomospecies 10) and Citrobacter murliniae sp. nov. (Formerly Citrobacter Genomospecies 11)

Abstract

Recent work describing six named species and two unnamed genomospecies within Citrobacter has enlarged the genus to 11 species. DNA relatedness and phenotypic tests were used to determine how well these species can be identified. One hundred thirty-six strains were identified to species level by DNA relatedness and then identified phenotypically in a blinded fashion. By using conventional tests, 119 of the 136 strains (88%) were correctly identified to species level. Three additional strains (2%) were identified as citrobacteria but were not identified to species level, and 14 strains (10%) were misidentified as other Citrobacter species. Carbon source utilization tests were used to identify 86 of the strains. Eighty-four strains (98%) were correctly identified, and two strains (2%) were misidentified as other Citrobacter species. Additional strains of Citrobacter genomospecies 10 and Citrobacter genomospecies 11 were identified, allowing these species to be formally named as Citrobacter gillenii sp. nov. and Citrobacter murliniae sp. nov., respectively.


Five named species and three unnamed genomospecies were recently added to the genus Citrobacter on the basis of DNA relatedness and biochemical studies (2). Based on this new classification, Janda et al. (8) identified 235 Citrobacter strains from the collection of the Microbial Diseases Laboratory, California Department of Health Services (CDHS), Berkeley. Additional strains of unnamed Citrobacter genomospecies 9 were subsequently identified and studied, resulting in this species being named Citrobacter rodentium (13).

The study reported herein had two goals. We sought to determine the extent to which the biochemical identification of the new, as well as the traditional, species Citrobacter freundii, Citrobacter koseri (Citrobacter malonaticus), and Citrobacter amalonaticus correlated with molecular identification. We also sought to obtain additional strains of the two remaining unnamed Citrobacter genomospecies and to formally name them. For these purposes, 136 Citrobacter strains were identified to species level by DNA hybridization, and the data were compared with the biochemical identifications of these strains. Additional strains of each of the two remaining unnamed Citrobacter genomospecies were identified, resulting in their formal description as Citrobacter gillenii sp. nov. (formerly Citrobacter genomospecies 10) and Citrobacter murliniae sp. nov. (formerly Citrobacter genomospecies 11).

MATERIALS AND METHODS

Strains.

Included in the study were 136 strains that, prior to the creation of additional Citrobacter species (2), had been identified as C. freundii, C. koseri, and C. amalonaticus on the basis of biochemical reactions. Eighty-six strains were sent to the diagnostic laboratories at the Centers for Disease Control and Prevention (CDC) from 1972 to 1986; 26 of these strains were from the Microbial Diseases Laboratory of the CDHS, having been received from 1970 to 1994; 13 strains were from the Culture Collection, University of Göteborg (CCUG), Göteborg, Sweden; eight strains were from the National Institute of Public Health (NIPH), Prague, Czechoslovakia; and three strains were from the Division of Toxicology and Division of Comparative Medicine, Massachusetts Institute of Technology (MIT), Cambridge, Mass.

Biochemical tests.

The methods used for the conventional biochemical tests done at the CDC and for the carbon source utilization tests (using Biotype strips [BioMérieux, La Balme les Grottes, France]) carried out at the Institut Pasteur have been described previously (2, 6, 7). In the present study, Biotype-100 strips were incubated at 30°C for 4 days. The CDC strains were identified both by conventional biochemical tests done at the CDC and by carbon source utilization tests carried out at the Institut Pasteur. The NIPH, CCUG, MIT, and the CDHS strains were also identified by conventional biochemical tests at CDC. The CDHS strains were also identified by conventional biochemical tests at the CDHS (8). In all cases, identification on the basis of either conventional biochemical tests or carbon source utilization tests was made by using the differential tables previously published by Brenner et al. (2).

DNA hybridization.

The methods used for DNA extraction and purification and the hydroxyapatite hybridization method for determining levels of DNA relatedness have been described previously (2, 4). Reactions were carried out at 60°C (for optimal DNA reassociation) and at 75°C (for stringent DNA reassociation). Percent divergence was determined by thermal elution of reassociated DNA on the assumption that each 1°C decrease in thermal stability within a reassociated DNA duplex was due to approximately 1% of nucleotide bases within that sequence being unpaired. Percent divergence was calculated to the nearest 0.5%. All DNA relatedness reactions were carried out at least twice.

RESULTS AND DISCUSSION

The standard used to identify strains was the genetic definition of a species on the basis of DNA relatedness, as recommended by Wayne et al. (14). This recommendation states that DNAs from strains of a given species are at least 70% related at optimal conditions for DNA reassociation (60°C incubation temperature in this study) and that divergence (unpaired bases) within related nucleotide sequences is 5% or less. We used the additional criterion that DNA relatedness of strains within a species remains above 60% in reactions carried out under stringent incubation conditions (75°C incubation temperature in this study). A strain was assigned to a given species when the relatedness of its DNA to labeled DNA from the type strain of that species fulfilled the species definition. The DNA relatedness data are summarized in Table 1. Relatedness values obtained with 131 of the 136 strains fully conformed to the molecular definition of a species. Of the five exceptions, two were closest to C. amalonaticus, two were closest to Citrobacter braakii, and one was closest to Citrobacter youngae. They each fulfilled two of the three criteria (percent divergence of less than 5 and relatedness of above 60% in 75°C reactions), but their relatedness in 60°C reactions was slightly under 70%. While it is possible that these five exceptions represent one or more new species, we decided that they were close enough to the species definition to merit provisional assignment to the species to which they were most closely related.

TABLE 1.

Summary valuesa of strains assigned to Citrobacter species on the basis of DNA relatedness

Species No. of strains Summary valueb
Avg
Low
60°C % D 75°C 60°C % D 75°C
C. freundii 46 85 1.5 79 70 4.5 60
C. koseri 2 79 0.5 75 77 0.0 75
C. amalonaticus 5 76 1.0 76 68 0.0 68
Citrobacter farmeri 1 71 1.5 70 71 1.5 70
C. youngae 29 81 2.5 77 69 4.5 62
C. braakii 16 82 0.5 79 63 0.5 61
C. werkmanii 10 78 2.0 77 71 2.5 68
Citrobacter sedlakii 6 83 1.0 78 73 0.5 75
C. rodentium 3 94 0.5  —c 92 0.5
Citrobacter genomospecies 10 11 86 1.0 92 76 3.5 78
Citrobacter genomospecies 11 7 91 0.5 91 87

All 136 strains were identified by conventional biochemical tests done at CDC. The 87 strains from the CDC collection were also identified by carbon source utilization tests. Personnel carrying out identification by any method were blinded to the results obtained with other methods.

One hundred nineteen of 136 strains (88%) were correctly identified on the basis of their biochemical profiles. Fourteen strains (10%) were misidentified as other species in the genus Citrobacter, and three strains (2%) were correctly identified as Citrobacter but were not identified to species level. Seven of the misidentified strains and one of the nonidentified strains were biochemically atypical C. freundii. The atypical characteristics most often seen were ornithine decarboxylase production (5 strains); indole production (3 strains); negative growth on citrate, negative fermentation of raffinose, and nonmotility (2 strains each); malonate utilization and fermentation of i-inositol (1 strain each); and negative fermentation of melibiose, negative production of H2S, and negative gas production from d-glucose (1 strain each).

These results are encouraging, indicating that despite changes in reaction percentages and the inclusion of a large number of atypical strains, the large majority of Citrobacter strains can be identified phenotypically by using conventional biochemical tests. O’Hara et al. (11) investigated the abilities of five commercial identification systems to recognize the newly defined species of Citrobacter by using the 112 strains identified by DNA hybridization in reference 1. Because the eight newly defined species were not included in the databases of any of these systems, most of these strains were identified as C. freundii.

The Vitek GNI+ card (BioMérieux Inc., Hazelwood, Mo.), which contains all 11 named and unnamed Citrobacter species, groups seven species which can be identified by using six additional conventional biochemical tests into the “Citrobacter freundii complex.” When evaluated by O’Hara et al. (12), 12 of 16 strains in this complex were correctly identified by using the additional tests. The database of the MicroScan Rapid Neg ID3 panel (Dade Behring, Inc., West Sacramento, Calif.) contains eight of the nine named Citrobacter species (C. rodentium is not included). When evaluated by Bascomb et al. (1), 14 of 15 strains of the newer species were correctly identified.

Revised biochemical test percentages for all Citrobacter species are presented in Table 2 and are compared with the biochemical table presented previously (2). It should be noted that many of the percentages presented in the previous paper were changed when the data were recalculated (Table 2, columns P). Most of the changes are small, but nonetheless, the Hospital Environment Laboratory Branch of the CDC considers these results to be a correction of and a replacement for those presented previously (2). While the addition of strains in the present study did not cause most reaction percentages to change significantly, there are a number of percentage shifts worthy of mention. This is especially true for C. freundii, whose biochemical profile originally included strains of the 10 subsequently recognized Citrobacter species (5). The significant percentage shifts include H2S production (formerly 96% and now 63%), sucrose fermentation (formerly 18% and now 78%), dulcitol fermentation (formerly 71% and now 24%), and raffinose fermentation (formerly 18% and now 88%). In each case, the actual percentage is probably closer to the former value, since that value is based on a 10-fold-higher number of strains (albeit including many that are not C. freundii) and a much higher percentage of typical strains.

TABLE 2.

Comparison of conventional biochemical reactions of citrobacteriaa

Test % Positive strainsb
C. freundii
C. koseri
C. amalonaticus
C. youngae
C. braakii
T (n = 429) P (n = 9) C (n = 49) P (n = 16) C (n = 17) P (n = 16) C (n = 17) P (n = 21) C (n = 39) P (n = 15) C (n = 24)
Indole 2 33 12 94 94 100 94 14 10 33 21
Citrate (Simmons) 88 (93) 78 (89) 80 (90) 100 100 100 100 76 (95) 74 (90) 87 (100) 75 (88)
H2S production (triple sugar iron) 93 (96) 78 (89) 59 (63) 0 0 13 12 67 (81) 74 (85) 60 41 (45)
Urease 79 (87) 44 (56) 57 (73) 50 (69) 59 (71) 88 (94) 88 (94) 76 69 47 (67) 38 (58)
Arginine deaminase 47 (88) 67 (100) 51 (100) 94 (100) 94 (100) 81 (100) 76 (94) 52 (90) 54 (90) 67 (100) 54 (100)
Ornithine decarboxylase 15 0 (11) 12 (14) 100 100 94 (100) 94 (100) 5 3 93 88
Motility 95 89 88 94 94 94 (100) 88 (94) 95 97 87 79
KCN 97 89 (100) 90 (100) 0 (6) 0 (6) 100 100 95 (100) 92 (95) 100 96 (100)
Malonate 22 11 8 94 94 0 0 5 3 (5) 0 0
d-Glucose (gas) 90 89 86 100 100 88 82 76 85 93 88
Acid produced from:
 Lactose 37 (91) 78 (89) 86 (92) 69 (94) 71 (88) 38 (100) 50 (100) 24 (90) 18 (90) 80 (87) 81 (86)
 Sucrose 17 (18) 89 73 (78) 44 47 0 6 19 21 7 13
 Dulcitol 71 11 24 38 41 0 0 86 74 33 46
 Salicin 3 (24) 0 (11) 6 (16) 6 (88) 6 (88) 12 (94) 18 (94) 10 5 0 (7) 0 (8)
 Raffinose 17 (18) 44 (89) 73 (86) 0 0 0 0 10 8 7 (13) 17 (21)
 Cellobiose 60 (99) 44 (77) 35 (82) 94 94 100 100 43 (100) 26 (77) 73 (93) 67 (96)
 α-CH3-glucoside 5 (14) 11 (33) 12 (22) 44 (94) 41 (88) 6 (19) 6 (18) 0 (5) 0 (5) 33 (46) 25 (38)
 Esculin 1 (2) 0 0 (10) 0 (31) 0 (29) 0 (25) 0 (35) 5 3 0 0 (4)
 Melibiose NTd 100 96 (98) 0 0 0 6 5 5 80 (100) 88 (100)
 Glycerol 99 (100) 100 100 100 100 31 (38) 41 (47) 90 (100) 92 (100) 87 92
Sodium acetate 77 (91) 44 (56) 78 (82) 88 (94) 88 (94) 94 94 67 (76) 64 (85) 53 (93) 54 (79)
NO3→NO2 99 100 100 100 100 94 94 86 92 100 100
ONPGc 99 89 88 (96) 100 100 94 94 95 95 80 83
Citrobacter speciesb
C. werkmanii
C. sedlakii
C. farmeri
C. rodentium
Genomospecies 10
Genomospecies 11
P (n = 6) C (n = 13) P (n = 6) C (n = 6) P (n = 14) C (n = 14) P (n = 3) C (n = 6) P (n = 3) C (n = 6) P (n = 3) C (n = 8)
0 0 100 100 100 100 0 0 0 0 100 100
100 92 83 (100) 83 (100) 0 (36) 0 (36) 0 (100) 0 (67) 33 (100) 50 (100) 100 88 (100)
100 92 0 0 0 0 0 0 67 83 67 75
100 92 100 100 43 43 100 83 (100) 0 0 67 (100) 63 (75)
100 77 (92) 100 100 100 100 0 0 33 (100) 17 (83) 67 (100) 50 (88)
0 0 100 100 100 100 100 100 0 0 0 0
100 100 100 100 100 100 0 0 (33) 67 83 100 100
100 100 100 100 100 100 0 0 100 100 100 100
100 92 100 100 0 0 100 100 100 100 0 0
100 92 100 100 100 100 100 100 100 100 100 100
17 (100) 23 (77) 100 100 14 (100) 4 (100) 100 100 67 67 (83) 67 (100) 63 (100)
0 0 0 0 100 100 0 0 33 17 33 25
0 8 100 100 0 0 0 0 0 0 100 100
0 0 (8) 17 (50) 17 (50) 0 (93) 0 (93) 0 (100) 0 (100) 0 (67) 17 (83) 0 (67) 13 (63)
0 0 0 0 100 100 0 0 0 17 33 13
0 (83) 8 (85) 100 100 100 100 100 100 67 83 100 100
0 0 0 0 100 100 0 0 0 0 0 0
0 0 (8) 17 (50) 17 (50) 0 (36) 0 (36) 0 (100) 0 (83) 0 (33) 17 (50) 0 (100) 0 (100)
0 0 100 100 100 100 0 0 67 83 33 (100) 38 (75)
100 100 83 83 79 79 0 0 (33) 67 (100) 67 (83) 100 100
100 92 83 83 79 (100) 79 (100) 0 (100) 0 (50) 0 (33) 0 (17) 33 (100) 75 (100)
100 100 100 100 100 100 100 100 100 100 100 100
100 100 100 100 100 100 100 100 67 (100) 83 (100) 100 100

The percentages obtained from the biochemical tests in this study revealed a few small, but significant, changes when compared to the percentages obtained in the recent previous study (2). This is not surprising given the small number of representative strains for most species. For C. braakii, delayed growth on citrate and delayed utilization of sodium acetate, and production of ornithine, and gas from glucose changed from positive to variable, and fermentation of glycerol changed from variable to positive. For Citrobacter werkmanii, production of arginine changed from rapid (within 48 h) positive to delayed positive. For C. rodentium, production of urease changed from positive to delayed positive, and motility changed from negative to delayed variable. For Citrobacter genomospecies 10, fermentation of salicin, raffinose, and esculin changed from negative to variable. For Citrobacter genomospecies 11, growth on citrate changed from positive to delayed positive, production of urease and arginine changed from delayed positive to variable, and fermentation of melibiose changed from delayed positive to delayed variable.

By using the species profiles generated in our previous study, 65 of the 86 strains (76%) tested by carbon source utilization were correctly identified. Fifteen strains (17%) were not identified to species level, and six (7%) were misidentified as other species in the genus Citrobacter. After adjustments were made in the identification program for carbon sources, all strains were retested and reidentified. Upon retesting, 84 of the strains (98%) were correctly identified and two (2%) were misidentified as other Citrobacter species. On the basis of carbon source utilization patterns, C. freundii strains formed seven clusters (biotypes) and C. braakii strains formed two clusters. Profiles for the biotypes and revised carbon source utilization patterns for all species are shown in Table 3. The C. braakii biotypes were separable by analysis of their abilities to utilize 4-aminobutyrate, lactose, d-lyxose, maltitol, 1-O-methyl-β-galactoside, 3-phenylpropionate, and propionate. C. freundii biotypes were separable on the basis of their profiles for use of the following carbon sources: trans-aconitate, 4-aminobutyrate, 5-aminovalerate, dulcitol, ethanolamine, 1-glutamate, myo-inositol, maltitol, 3-O-methyl-d-glucose, 1-O-methyl-α-d-glucoside, palatinose, 3-phenylpropionate, propionate, putrescine, sucrose, meso-tartrate, and d-turanose.

TABLE 3.

Carbon source utilization by Citrobacter speciesa

Carbon source Citrobacter speciesb
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
cis-Aconitate 82 50 100 100 60 25 100 100 94 100 100 90 71 94 100 43 100 88
trans-Aconitate 36 0 17 33 0 0 0 0 0 69 100 0 57 65 0 43 11 0
Adonitol 0 0 0 0 0 0 0 0 6 0 0 0 0 94 0 0 0 0
4-Aminobutyrate 36 0 72 100 60 25 0 0 71 62 50 50 21 6 17 0 11 75
5-Aminovalerate 64 0 89 100 40 100 50 40 65 85 50 64 36 41 56 0 44 88
d-Arabitol 0 0 0 0 0 0 0 0 0 0 0 2 0 100 0 0 0 0
Benzoate 0 0 0 0 0 0 0 0 0 0 100 0 93 0 78 0 0 0
Caprate 0 0 11 0 20 0 0 0 0 0 17 5 7 53 22 0 0 0
d-Cellobiose 91 100 94 100 100 75 50 100 100 100 100 83 100 94 100 100 89 100
m-Coumarate 100 100 100 0 100 100 100 80 100 100 67 95 0 0 0 0 78 25
Dulcitol 27 50 28 67 0 0 50 40 41 8 100 76 0 47 0 0 0 100
Esculin 0 0 0 0 0 0 0 0 6 0 50 5 0 0 0 0 22 13
Ethanolamine 45 50 22 67 40 0 0 0 6 38 33 33 14 82 67 0 0 38
l-Fucose 100 100 100 100 80 100 100 80 94 100 100 95 100 100 100 57 89 100
Gentiobiose 100 100 94 100 100 75 50 100 100 77 100 71 100 88 100 14 78 100
Gentisate 100 100 94 100 100 100 100 100 100 92 100 0 100 100 100 57 22 25
l-Glutamate 100 100 94 100 100 100 0 100 100 100 100 95 100 100 100 57 78 88
dl-Glycerate 100 100 100 100 100 100 50 80 94 85 100 98 100 100 100 100 100 100
Glycerol 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 29 100 100
3-Hydroxybenzoate 100 100 94 100 100 100 100 100 100 92 100 0 100 100 100 100 22 25
4-Hydroxybenzoate 0 0 0 0 0 0 0 0 0 0 100 0 100 0 100 0 0 0
3-Hydroxybutyrate 91 50 100 100 100 100 50 60 65 100 100 88 7 12 28 0 22 88
myo-Inositol 73 0 89 33 40 75 50 0 0 23 100 0 0 100 0 0 89 0
5-Ketogluconate 100 100 100 100 100 100 100 100 100 69 0 100 100 100 0 0 100 100
2-Ketoglutarate 55 100 22 67 40 50 0 20 65 69 100 21 36 6 39 0 33 50
dl-Lactate 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 29 100 100
Lactose 100 100 100 33 40 100 100 20 100 38 100 45 86 88 89 100 89 100
Lactulose 100 50 94 33 40 75 50 20 94 23 100 0 7 0 0 29 56 50
d-Lyxose 64 100 89 67 60 50 0 40 94 100 67 57 7 100 0 0 56 100
Malonate 9 0 6 0 0 0 0 0 0 92 83 0 0 88 0 100 0 0
Maltitol 100 100 0 0 0 0 0 100 47 0 0 2 93 100 6 0 0 0
d-Melibiose 91 100 100 100 100 75 100 100 100 8 100 0 100 0 6 0 100 63
1-O-Methyl-α-galactoside 91 100 100 100 100 75 100 100 100 8 100 10 100 0 0 0 100 88
1-O-Methyl-β-galactoside 100 100 100 33 20 100 100 20 100 92 100 86 43 100 39 100 89 100
3-O-Methyl-d-glucose 36 100 28 100 0 25 0 100 100 62 100 0 100 12 89 0 11 25
1-O-Methyl-α-d-glucoside 100 100 0 0 0 0 0 80 41 0 0 0 93 100 11 0 0 0
1-O-Methyl-β-d-glucoside 100 100 100 100 100 75 100 100 100 100 100 100 100 100 100 14 100 100
Palatinose 100 100 0 0 0 0 0 100 59 0 0 2 100 100 11 0 11 25
Phenylacetate 45 0 44 0 60 25 50 0 0 0 0 0 0 0 0 0 78 0
3-Phenylpropionate 100 100 94 0 100 50 100 40 88 92 0 95 0 0 0 0 67 25
l-Proline 100 50 100 100 80 100 100 100 100 100 100 86 71 100 89 100 67 100
Propionate 100 0 100 33 60 75 100 40 94 100 100 93 86 88 78 100 67 100
Protocatechuate 0 0 0 0 0 0 0 0 0 0 100 0 100 0 100 0 0 0
Putrescine 82 0 83 33 20 25 100 40 71 77 0 0 0 0 0 100 11 25
d-Raffinose 91 100 100 100 100 75 100 0 24 0 0 0 100 0 0 0 22 25
l-Sorbose 82 50 100 100 100 100 100 20 12 77 0 100 100 0 83 0 11 100
Sucrose 100 50 89 0 20 100 100 0 0 0 0 14 100 47 6 0 11 25
d-Tagatose 18 0 11 67 20 25 0 0 0 0 0 7 43 0 0 0 0 0
d-Tartrate 9 0 11 0 0 0 50 0 6 100 0 5 0 0 6 0 11 0
l-Tartrate 55 50 50 100 0 50 0 60 76 85 50 67 64 76 72 86 11 63
meso-Tartrate 82 100 67 100 80 0 100 100 94 92 83 93 21 0 89 100 0 88
Tricarballylate 100 100 89 100 40 100 100 100 94 92 100 10 100 0 94 100 22 100
d-Turanose 73 50 0 0 0 0 0 20 18 0 0 0 36 35 11 0 0 0
l-Tyrosine 82 50 78 100 60 75 0 100 94 100 0 83 0 88 0 0 44 75
Xylitol 0 0 0 0 0 0 0 0 0 0 0 0 0 53 0 0 0 0

Additional strains of each unnamed Citrobacter genomospecies were identified on the basis of DNA relatedness and biochemical studies. Three additional strains confirmed to be Citrobacter genomospecies 9 were obtained from David B. Schauer. As with the three initially reported strains of this species, the additional strains were all from mice and were causative agents of transmissible murine colonic hyperplasia (13). The six strains of Citrobacter genomospecies 9 were recently described as the new species C. rodentium (13).

Eleven additional strains of Citrobacter genomospecies 10 were identified, for a total of 14, and seven additional strains of Citrobacter genomospecies 11 were identified, for a total of 10. The names “Citrobacter gillenii” sp. nov. and “Citrobacter murliniae” sp. nov. are proposed below for Citrobacter genomospecies 10 and for Citrobacter genomospecies 11, respectively.

Where known, the sources of isolation of the strains used in the present and in the previous studies (2) are shown in Table 4. It seems clear that all Citrobacter species other than C. rodentium are predominantly isolated from human clinical specimens.

TABLE 4.

Sources of isolation for Citrobacter isolates

Taxon No. of strains isolated froma:
Stool Urine CSF Blood Wound Sputum Other Animal Environment
C. koseri 4 19 15 6 3 7 2 1 1
C. amalonaticus 35 3 5 4 1 1 1
C. farmeri 25 6 2 6 1 1
C. freundii 21 13 1 3 3 2 1 7
C. youngae 33 3 1 3 3 4
C. braakii 14 2 1 2 2
C. werkmanii 9 2 2 1 1
C. sedlakii 8 1 1 1
C. rodentium 6
C. gillenii 9 1 1 1 2
C. murliniae 5 1 1 2 1

Description of Citrobacter gillenii sp. nov.

Citrobacter gillenii (gil.len′i.i. N.L. gen. n. gillenii, to honor George Francis Gillen, an American microbiologist, who, along with C. H. Werkman, studied the fermentative production of trimethylene glycol from glycerol and proposed the genus Citrobacter [15]). Formerly called Citrobacter genomospecies 10. It is negative for the production of indole and ornithine decarboxylase, positive for utilization of malonate, and delayed positive for growth on citrate and usually for production of arginine dihydrolase. Other biochemical characteristics useful for differentiation are negative reactions for production of urease and fermentation of dulcitol and the inability to utilize gentisate, 3-hydroxybenzoate, 3-O-CH3-d-glucose, l-sorbose, and tricarballylate as sole carbon sources (2). Complete results of routine biochemical reactions are given in Table 2, and complete carbon source utilization reactions are given in Table 3.

Known sources of isolation are human stool (nine strains); human urine, human blood, and animal stool (one strain each); and the environment (two strains). There is insufficient information to speculate on the clinical significance of C. gillenii. The type strain is CDC 4693-86 (ATCC 51117 and CCUG 30796), which was isolated from a human stool in France.

Description of Citrobacter murliniae sp. nov.

Citrobacter murliniae (mur.lin′i.ae. N.L. gen. n. murliniae, to honor Alma C. McWhorter-Murlin, an American microbiologist, who, during her 39-year career at the Centers for Disease Control and Prevention, made substantial contributions to our knowledge of Salmonella serotyping and Citrobacter and to the taxonomy of a number of species in the family Enterobacteriaceae [3, 4, 9, 10]). Formerly called Citrobacter genomospecies 11. It is positive or delayed positive for production of indole and growth on citrate, usually delayed positive for production of arginine dihydrolase, and negative for production of ornithine decarboxylase. Other biochemical tests useful for differentiation are acid production from dulcitol and esculin (delayed), growth on sodium acetate (usually delayed) but not on malonate, and the ability to utilize dulcitol, d-lyxose, 1-O-CH3-α-galactoside (delayed), and l-tyrosine, but not malonate and protocatechuate, as sole carbon sources. Complete results of routine biochemical reactions are given in Table 2, and complete carbon source utilization reactions are given in Table 3.

Known sources of isolation are human stool (five strains); human wound (two strains); and human blood, human urine, and food (one strain each). There is insufficient information to speculate on the pathogenicity of C. murliniae. The type strain is CDC 2970-59 (ATCC 51118 and CCUG 30797), which was isolated from an unknown source in Illinois.

ACKNOWLEDGMENTS

E.A. and J.S. were supported in part by grant IGA 1628-3 from the Internal Grant Agency of the Czech Ministry of Health.

REFERENCES

  • 1.Bascomb S, Abbott S L, Bobolis J D, Bruckner D A, Connell S J, Cullen S K, Daugherty M, Glenn D, Janda J M, Lentsch S J, Lindquist D, Mayhew P B, Nothaft D M, Skinner J R, Williams G B, Wong J, Zimmer B L. Multicenter evaluation of the MicroScan rapid gram-negative identification type 3 panel. J Clin Microbiol. 1997;35:2531–2536. doi: 10.1128/jcm.35.10.2531-2536.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Brenner D J, Grimont P A D, Steigerwalt A G, Fanning G R, Ageron E, Riddle C F. Classification of citrobacteria by DNA hybridization: designation of Citrobacter farmeri sp. nov., Citrobacter youngae sp. nov., Citrobacter braakii sp. nov., Citrobacter werkmanii sp. nov., Citrobacter sedlakii sp. nov., and three unnamed Citrobacter genomospecies. Int J Syst Bacteriol. 1993;43:645–658. doi: 10.1099/00207713-43-4-645. [DOI] [PubMed] [Google Scholar]
  • 3.Brenner D J, McWhorter A, Kai A, Steigerwalt A G, Farmer J J., III Enterobacter asburiae: a new species found in human clinical specimens, and reassignment of Erwinia dissolvens and Erwinia nimipressuralis to the genus Enterobacter as Enterobacter dissolvens comb. nov. and Enterobacter nimipressuralis comb. nov. J Clin Microbiol. 1986;23:1114–1120. doi: 10.1128/jcm.23.6.1114-1120.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Brenner D J, McWhorter A C, Leete Knutson J K, Steigerwalt A G. Escherichia vulneris: a new species of Enterobacteriaceae associated with human wounds. J Clin Microbiol. 1982;15:1133–1140. doi: 10.1128/jcm.15.6.1133-1140.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ewing W H. Edwards and Ewing’s identification of Enterobacteriaceae. 4th ed. New York, N.Y: Elsevier; 1986. pp. 346–347. [Google Scholar]
  • 6.Farmer J J, III, Asbury M A, Hickman F W, Brenner D J the Enterobacteriaceae Study Group. Enterobacter sakazakii: a new species of “Enterobacteriaceae” isolated from clinical specimens. Int J Syst Bacteriol. 1980;30:569–584. [Google Scholar]
  • 7.Hickman F W, Farmer J J., III Salmonella typhi: identification, antibiograms, serology, and bacteriophage typing. Am J Med Technol. 1978;44:1149–1159. [PubMed] [Google Scholar]
  • 8.Janda J M, Abbott S L, Cheung W K, Hanson D F. Biochemical identification of citrobacteria in the clinical laboratory. J Clin Microbiol. 1994;32:1850–1854. doi: 10.1128/jcm.32.8.1850-1854.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.McWhorter A C, Haddock R L, Nocon F A, Steigerwalt A G, Brenner D J, Aleksic S, Böckemuhl J, Farmer J J., III Trabulsiella guamensis, a new genus and species of the family Enterobacteriaceae that resembles Salmonella subgroups 4 and 5. J Clin Microbiol. 1991;29:1480–1485. doi: 10.1128/jcm.29.7.1480-1485.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.McWhorter-Murlin A C, Hickman-Brenner F W. Identification and serotyping of Salmonella and an update of the Kauffmann-White scheme. Atlanta, Ga: Centers for Disease Control and Prevention; 1994. [Google Scholar]
  • 11.O’Hara C M, Roman S B, Miller J M. Ability of commercial identification systems to identify newly recognized species of Citrobacter. J Clin Microbiol. 1995;33:242–245. doi: 10.1128/jcm.33.1.242-245.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.O’Hara C M, Westbrook G L, Miller J M. Evaluation of Vitek GNI+ and Becton Dickinson Microbiology Systems Crystal E/NF identification systems for identification of members of the family Enterobacteriaceae and other gram-negative, glucose-fermenting and non-glucose-fermenting bacilli. J Clin Microbiol. 1997;35:3269–3273. doi: 10.1128/jcm.35.12.3269-3273.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Schauer D B, Zabel B A, Pedraza I F, O’Hara C M, Steigerwalt A G, Brenner D J. Genetic and biochemical characterization of Citrobacter rodentium sp. nov. J Clin Microbiol. 1995;33:2064–2068. doi: 10.1128/jcm.33.8.2064-2068.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wayne L G, Brenner D J, Colwell R R, Grimont P A D, Kandler O, Krichevsky M I, Moore L H, Moore W E C, Murray R G E, Stackebrandt E, Starr M P, Trüper H G. Report of the ad hoc committee on reconciliation of approaches to bacterial systematics. Int J Syst Bacteriol. 1987;37:463–464. [Google Scholar]
  • 15.Werkman C H, Gillen G F. Bacteria producing trimethylene glycol. J Bacteriol. 1932;23:167–182. doi: 10.1128/jb.23.2.167-182.1932. [DOI] [PMC free article] [PubMed] [Google Scholar]